Literature DB >> 28978966

Safety of Eluxadoline in Patients With Irritable Bowel Syndrome.

Ryan Croteau1, Jamie S Barkin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28978966     DOI： 10.1038/ajg.2017.249

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

1.  A new source of drug-induced acute pancreatitis: codeine.

Authors:  P Hastier; M J Buckley; E P Peten; N Demuth; R Dumas; J F Demarquay; F X Caroli-Bosc; J P Delmont
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

2.  Influence of cholecystectomy on sphincter of Oddi motility.

Authors:  W Luman; A J Williams; A Pryde; G D Smith; S J Nixon; R C Heading; K R Palmer
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

3.  Change in bile duct pressure responses after cholecystectomy: loss of gallbladder as a pressure reservoir.

Authors:  M Tanaka; S Ikeda; F Nakayama
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

4.  Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.

Authors:  Brooks D Cash; Brian E Lacy; Philip S Schoenfeld; Leonard S Dove; Paul S Covington
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

5.  Prior cholecystectomy predisposes to acute pancreatitis in codeine-prescribed patients.

Authors:  Serdar Turkmen; Hakan Buyukhatipoglu; Ali Suner; Haci Gokhan Apucu; Turgay Ulas
Journal:  Int J Crit Illn Inj Sci       Date:  2015 Apr-Jun
  5 in total
  1 in total

Review 1.  Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives.

Authors:  Rebecca Liu; Kyle Staller
Journal:  Drug Des Devel Ther       Date:  2020-04-09       Impact factor: 4.162
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.